Literature DB >> 1438807

Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carcinomas.

M R Berger1, P Yanapirut, M Reinhardt, T Klenner, H R Scherf, H H Schmeiser, H Eibl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1438807     DOI： 10.1159/000420836

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  5 in total

1.  [Spectrographic studies on the radioresistance of Miltex and miltefosine].

Authors:  G Bollmann; H Paukisch; E Bothe; W Strate; G Gademann
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

2.  Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins.

Authors:  Ilina K Dineva; Maya M Zaharieva; Spiro M Konstantinov; Hansjörg Eibl; Martin R Berger
Journal:  J Cancer Res Clin Oncol       Date:  2012-06-30       Impact factor: 4.553

3.  Hexadecylphosphocholine differs from conventional cytostatic agents.

Authors:  M R Berger; B Betsch; M Gebelein; E Amtmann; P Heyl; H R Scherf
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Pharmacokinetic behavior and antineoplastic activity of liposomal hexadecylphosphocholine.

Authors:  P Kaufmann-Kolle; J Drevs; M R Berger; J Kötting; N Marschner; C Unger; H Eibl
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 5.  Multiple Facets of Autophagy and the Emerging Role of Alkylphosphocholines as Autophagy Modulators.

Authors:  Ferda Kaleağasıoğlu; Doaa M Ali; Martin R Berger
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.